Quantcast

Latest Aethlon Medical Inc. Stories

2011-04-15 15:01:00

SAN DIEGO, April 15, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, disclosed today that InvestorIdeas.com has released an interview with Aethlon CEO Jim Joyce regarding broad spectrum treatment strategies to address HIV, Hepatitis C and other infectious disease conditions. The interview can be accessed online at: http://www.investorideas.com/CO/AEMD/news/2011/04141.asp (Photo:...

2011-04-12 08:01:00

SAN DIEGO, April 12, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD) announced today that its wholly owned subsidiary Exosome Sciences, Inc. (ESI) has validated the ability of its Enzyme Linked Lectin Specific Assay (ELLSA) to identify the presence of exosomes underlying the human immunodeficiency virus (HIV), tuberculosis (TB), and various forms of cancer, including ovarian, melanoma, breast, lymphoma, and colorectal. In July 2010, ESI disclosed that it filed a patent relating...

2011-04-06 07:31:00

SAN DIEGO, April 6, 2011 /PRNewswire/ -- Aethlon Medical, Inc., (OTCBB: AEMD) disclosed today that its Chairman and CEO, James A. Joyce has issued the following letter to shareholders. (Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b) To our Shareholders: On April 1st, we submitted a contract response to the Defense Advanced Research Projects Agency (DARPA) related to the Dialysis Like Therapeutics (DLT) program referenced in my last shareholder letter. In our...

2011-04-01 09:57:00

SAN DIEGO, April 1, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, disclosed today that InvestorIdeas.com has released the second installment of an interview regarding emerging opportunities in the biodefense industry that was conducted with Aethlon CEO, Jim Joyce. The interview can be accessed online at: http://www.investorideas.com/CO/AEMD/news/2011/04011.asp (Photo:...

2011-03-08 07:01:00

SAN DIEGO, March 8, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that the U.S. Food and Drug Administration (FDA) has granted Aethlon's request to export its Hemopurifier® medical device to India. (Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b) The FDA's approval was granted under Section 801 (e) of the Federal...

2011-02-15 06:30:00

SAN DIEGO, Feb. 15, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it will present at the Wall Street Analyst Forum 22nd Annual Investor Conference on Tuesday, March 1, 2011 at 9:05 A.M. (EST). Aethlon Medical's Chairman and CEO, James A. Joyce, will present a corporate overview and will meet with investors during a series of one-on-one breakout...

2011-02-10 07:37:00

SAN DIEGO, Feb. 10, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that its President, Rod Kenley, was invited to present at the 4th Congress of the International Society for Hemodialysis (ISHD-2011) in India. The subject of his presentation is "The Treatment of HCV with Affinity Plasmapheresis." The conference will be held in New Delhi, India on March...

2011-01-05 07:30:00

SAN DIEGO, Jan. 5, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it will host an investor event at 5:30 pm PST on January 20, 2011 at the Hyatt Regency La Jolla at Aventine located at 3777 La Jolla Village Drive, San Diego, California, 92122. (Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b) Jim Joyce, Chairman and Chief...

2010-12-20 13:40:00

SAN DIEGO, Dec. 20, 2010 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it will host a presentation for shareholders and other interested parties at 5:30 pm EST on January 12, 2011. (Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b) The event will be held at the offices of Fabiani & Company located at 1100 Pennsylvania...

2010-12-20 05:30:00

SAN DIEGO, Dec. 20, 2010 /PRNewswire/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it has demonstrated the ability to capture immunosuppressive exosomes derived from individuals with lymphoma and colorectal cancer. (Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b) In the lymphoma study, conducted at the City of Hope Cancer Research Hospital in...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related